Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 19;24(3):102188.
doi: 10.1016/j.isci.2021.102188. Epub 2021 Feb 12.

Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors

Collaborators, Affiliations

Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors

Timothy S Chang et al. iScience. .

Abstract

Coronavirus disease 2019 (COVID-19) has exposed health care disparities in minority groups including Hispanics/Latinxs (HL). Studies of COVID-19 risk factors for HL have relied on county-level data. We investigated COVID-19 risk factors in HL using individual-level, electronic health records in a Los Angeles health system between March 9, 2020, and August 31, 2020. Of 9,287 HL tested for SARS-CoV-2, 562 were positive. HL constituted an increasing percentage of all COVID-19 positive individuals as disease severity escalated. Multiple risk factors identified in Non-Hispanic/Latinx whites (NHL-W), like renal disease, also conveyed risk in HL. Pre-existing nonrheumatic mitral valve disorder was a risk factor for HL hospitalization but not for NHL-W COVID-19 or HL influenza hospitalization, suggesting it may be a specific HL COVID-19 risk. Admission laboratory values also suggested that HL presented with a greater inflammatory response. COVID-19 risk factors for HL can help guide equitable government policies and identify at-risk populations.

Keywords: public health; virology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

None
Graphical abstract
Figure 1
Figure 1
Flow diagram of subjects included in COVID-19 susceptibility, inpatient, and severe analyses for pre-existing conditions and medications
Figure 2
Figure 2
Association of known risk factors with COVID-19 outcomes Odds ratios for known risk factor phecode categories correcting for age and sex in (A) COVID-19 positive versus negative, (B) COVID-19 positive Inpatient versus Outpatient, and (C) COVID-19 positive Inpatient Severe versus Not Severe. Hispanics/Latinxs (blue) and Non-Hispanic/Latinx whites (purple). 95% confidence intervals for odds ratios are shown. Solid lines indicate risk factors that are nominally significant. Dotted lines are not nominally significant. COPD, chronic obstructive pulmonary disease. Related to Table S1.
Figure 3
Figure 3
Significant pre-existing condition risk factors for COVID-19 inpatient admission correcting for age and sex grouped by phecode category, related to Tables S3, S4, S5, S6, and S7 Hispanics/Latinxs (blue) and Non-Hispanic/Latinx whites (purple). 95% confidence intervals for odds ratios are shown. Solid lines indicate risk factors that are Bonferroni significant. Dotted lines are not Bonferroni significant. inf, infectious; heme, hematopoietic; Bonf, Bonferroni

References

    1. Ali H., Daoud A., Mohamed M.M., Salim S.A., Yessayan L., Baharani J., Murtaza A., Rao V., Soliman K.M. Survival rate in acute kidney injury superimposed COVID-19 patients: a systematic review and meta-analysis. Ren. Fail. 2020;42:393–397. - PMC - PubMed
    1. Argenziano M.G., Bruce S.L., Slater C.L., Tiao J.R., Baldwin M.R., Barr R.G., Chang B.P., Chau K.H., Choi J.J., Gavin N. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369:m1996. - PMC - PubMed
    1. Ayalew T. UpToDate; 2020. Approach to the Patient with Thrombocytosis.
    1. Blanco-Melo D., Nilsson-Payant B.E., Liu W.-C., Uhl S., Hoagland D., Møller R., Jordan T.X., Oishi K., Panis M., Sachs D. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036–1045.e9. - PMC - PubMed
    1. Brandt E.B., Beck A.F., Mersha T.B. Air pollution, racial disparities, and COVID-19 mortality. J. Allergy Clin. Immunol. 2020;146:61–63. - PMC - PubMed

LinkOut - more resources